{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:29:18Z","timestamp":1787030958638,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13346-024-01764-x","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T11:17:50Z","timestamp":1737026270000},"page":"2710-2721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and in vitro\/in vivo evaluation of taste-masked orodispersible films of dapoxetine hydrochloride using ion exchange resins"],"prefix":"10.1007","volume":"15","author":[{"given":"Ying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangcheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0964-2558","authenticated-orcid":false,"given":"Jinsong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"11","key":"1764_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41585-022-00639-5","volume":"19","author":"M Gul","year":"2022","unstructured":"Gul M, Bocu K, Serefoglu EC. Current and emerging treatment options for premature ejaculation. Nat Rev Urol. 2022;19(11):659\u201380. https:\/\/doi.org\/10.1038\/s41585-022-00639-5.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"1764_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18502\/ijrm.v19i1.8176","volume":"19","author":"AV Raveendran","year":"2021","unstructured":"Raveendran AV, Agarwal A. Premature ejaculation - current concepts in the management: a narrative review. Int J Reprod Biomed. 2021;19(1):5\u201322. https:\/\/doi.org\/10.18502\/ijrm.v19i1.8176.","journal-title":"Int J Reprod Biomed"},{"issue":"3","key":"1764_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/andr.13401","volume":"11","author":"E Colonnello","year":"2023","unstructured":"Colonnello E, Sansone A, Jannini EA. Erectile dysfunction, anxiety, perceived stress, and insomnia are more common among acquired premature ejaculation patients in contrast to other premature ejaculation syndromes. Andrology. 2023;11(3):433\u20134. https:\/\/doi.org\/10.1111\/andr.13401.","journal-title":"Andrology"},{"issue":"10","key":"1764_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/14656566.2018.1494725","volume":"19","author":"MD Waldinger","year":"2018","unstructured":"Waldinger MD. Drug treatment options for premature ejaculation. Expert Opin Pharmacother. 2018;19(10):1077\u201385. https:\/\/doi.org\/10.1080\/14656566.2018.1494725.","journal-title":"Expert Opin Pharmacother"},{"key":"1764_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.5534\/wjmh.230030","volume":"42","author":"HY Lee","year":"2023","unstructured":"Lee HY, Pyun JH, Shim SR, Kim JH. Efficacy of various treatment in premature ejaculation: systematic review and network Meta-analysis. World J Mens Health. 2023;42:338\u201346. https:\/\/doi.org\/10.5534\/wjmh.230030.","journal-title":"World J Mens Health"},{"issue":"3","key":"1764_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/2090598x.2021.1943273","volume":"19","author":"R Saleh","year":"2021","unstructured":"Saleh R, Majzoub A, Abu El-Hamd M. An update on the treatment of premature ejaculation: a systematic review. Arab J Urol. 2021;19(3):281\u2013302. https:\/\/doi.org\/10.1080\/2090598x.2021.1943273.","journal-title":"Arab J Urol"},{"issue":"2","key":"1764_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1464-410X.2006.05911.x","volume":"97","author":"KE Andersson","year":"2006","unstructured":"Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for \u2018on-demand\u2019 treatment of premature ejaculation. BJU Int. 2006;97(2):311\u20135. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.05911.x.","journal-title":"BJU Int"},{"issue":"5","key":"1764_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41443-019-0146-7","volume":"31","author":"Z Qin","year":"2019","unstructured":"Qin Z, Wang Y, Zhu J, Zhu K, Li R, Zhang L, et al. Safety and efficacy characteristics of oral drugs in patients with premature ejaculation: a bayesian network meta-analysis of randomized controlled trials. Int J Impot Res. 2019;31(5):356\u201368. https:\/\/doi.org\/10.1038\/s41443-019-0146-7.","journal-title":"Int J Impot Res"},{"issue":"5","key":"1764_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1756287212453866","volume":"4","author":"CG McMahon","year":"2012","unstructured":"McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012;4(5):233\u201351.","journal-title":"Ther Adv Urol"},{"issue":"1","key":"1764_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.sxmr.2018.05.001","volume":"7","author":"H Porst","year":"2019","unstructured":"Porst H, Burri A. Novel treatment for premature ejaculation in the light of currently used therapies: a review. Sex Med Rev. 2019;7(1):129\u201340. https:\/\/doi.org\/10.1016\/j.sxmr.2018.05.001.","journal-title":"Sex Med Rev"},{"key":"1764_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/sexmed\/qfac007","volume":"20","author":"A Sansone","year":"2023","unstructured":"Sansone A, Frangione V, Lanzarotti A, Cocci A, Ceruti C, De Sio M, et al. The effect of the new 75\u00a0mg orodispersible film of sildenafil on erection and sexual quality of life: insights from an observational study. J Sex Med. 2023;20:56. https:\/\/doi.org\/10.1093\/sexmed\/qfac007.","journal-title":"J Sex Med"},{"key":"1764_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2147\/dddt.S155040","volume":"12","author":"SI Park","year":"2018","unstructured":"Park SI, Heo SH, Kim G, Chang S, Song KH, Kim MG, et al. Comparison of tadalafil pharmacokinetics after administration of a new orodispersible film versus a film-coated tablet. Drug Des Devel Ther. 2018;12:935\u201342. https:\/\/doi.org\/10.2147\/dddt.S155040.","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"1764_CR13","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.3390\/pharmaceutics15122753","volume":"15","author":"S Jacob","year":"2023","unstructured":"Jacob S, Boddu SHS, Bhandare R, Ahmad SS, Nair AB. Orodispersible films: current innovations and emerging trends. Pharmaceutics. 2023;15(12):2753. https:\/\/doi.org\/10.3390\/pharmaceutics15122753.","journal-title":"Pharmaceutics"},{"issue":"2","key":"1764_CR14","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1002\/mba2.34","volume":"2","author":"Y Tian","year":"2023","unstructured":"Tian Y, Lin J, Jing H, Wang Q, Wu Z, Duan Y. Recent progress in orodispersible films-mediated therapeutic applications: a review. MedComm Biomater Appl. 2023;2(2):e34. https:\/\/doi.org\/10.1002\/mba2.34.","journal-title":"MedComm Biomater Appl"},{"key":"1764_CR15","doi-asserted-by":"publisher","unstructured":"Morath B, Sauer S, Zaradzki M, Wagner AH. Orodispersible films \u2013 recent developments and new applications in drug delivery and therapy. Biochem Pharmacol. 2022;200. https:\/\/doi.org\/10.1016\/j.bcp.2022.115036.","DOI":"10.1016\/j.bcp.2022.115036"},{"issue":"3","key":"1764_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.5740\/jaoacint.15-0259","volume":"99","author":"MN Patel","year":"2016","unstructured":"Patel MN, Kothari CS. Multivariate approaches for simultaneous determination of Avanafil and Dapoxetine by UV Chemometrics and HPLC-QbD in Binary mixtures and Pharmaceutical product. J AOAC Int. 2016;99(3):649\u201363. https:\/\/doi.org\/10.5740\/jaoacint.15-0259.","journal-title":"J AOAC Int"},{"key":"1764_CR17","doi-asserted-by":"publisher","first-page":"103100","DOI":"10.1016\/j.jddst.2022.103100","volume":"68","author":"AR Gardouh","year":"2022","unstructured":"Gardouh AR, Elhusseiny S, Gad S. Mixed Avanafil and Dapoxetin Hydrochloride cyclodextrin nano-sponges: Preparation, in-vitro characterization, and bioavailability determination. J Drug Deliv Sci Technol. 2022;68:103100. https:\/\/doi.org\/10.1016\/j.jddst.2022.103100.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1764_CR18","unstructured":"Australian Public Assessment Report for Dapoxetine. Department of Health and Ageing Therapeutic Goods Administration. 2010. https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-priligy.pdf. Accessed Nov 2010."},{"key":"1764_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s13346-023-01451-3","volume":"14","author":"IA Chacko","year":"2023","unstructured":"Chacko IA, Ramachandran G, Sudheesh MS. Unmet technological demands in orodispersible films for age-appropriate paediatric drug delivery. Drug Deliv Transl Res. 2023;14:841\u201357. https:\/\/doi.org\/10.1007\/s13346-023-01451-3.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"1764_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2021036885","volume":"39","author":"QU Khan","year":"2022","unstructured":"Khan QU, Siddique MI, Sarfraz M, Rehman K, Sohail MF, Katas H. Oral Dispersible films from Product Development to end-user acceptability: a review. Crit Rev Ther Drug Carrier Syst. 2022;39(1):33\u201364. https:\/\/doi.org\/10.1615\/CritRevTherDrugCarrierSyst.2021036885.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"1764_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1208\/s12249-023-02520-z","volume":"24","author":"SQ Hu","year":"2023","unstructured":"Hu SQ, Liu XX, Zhang SS, Quan DY. An overview of taste-Masking technologies: approaches, application, and Assessment methods. AAPS PharmSciTech. 2023;24:67. https:\/\/doi.org\/10.1208\/s12249-023-02520-z.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"1764_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/pharmaceutics10030157","volume":"10","author":"X Zheng","year":"2018","unstructured":"Zheng X, Wu F, Hong YL, Shen L, Lin X, Feng Y. Developments in taste-masking techniques for Traditional Chinese Medicines. Pharmaceutics. 2018;10(3):157. https:\/\/doi.org\/10.3390\/pharmaceutics10030157.","journal-title":"Pharmaceutics"},{"issue":"3","key":"1764_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.22376\/ijpbs\/lpr.2020.10.3.P88-96","volume":"10","author":"P Thakker","year":"2020","unstructured":"Thakker P, Shah J, Mehta T, Agarwal G. Taste masking of Pharmaceutical formulations: review on technologies, recent trends and patents. Int J Life Sci Pharma Res. 2020;10(3):88\u201396. https:\/\/doi.org\/10.22376\/ijpbs\/lpr.2020.10.3.P88-96.","journal-title":"Int J Life Sci Pharma Res"},{"key":"1764_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1208\/s12249-022-02260-6","volume":"23","author":"TY Zhang","year":"2022","unstructured":"Zhang TY, Du RF, Wang YJ, Hu JL, Wu F, Feng Y. Research Progress of Preparation Technology of Ion-Exchange Resin complexes. AAPS PharmSciTech. 2022;23:105. https:\/\/doi.org\/10.1208\/s12249-022-02260-6.","journal-title":"AAPS PharmSciTech"},{"key":"1764_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jddst.2018.12.002","volume":"49","author":"X Han","year":"2019","unstructured":"Han X, Zhang S, Chai Z, Dong Y, He W, Yin L, et al. In vitro and in vivo evaluation of the taste-masking efficiency of Amberlite IRP88 as drug carries in chewable tablets. J Drug Deliv Sci Technol. 2019;49:547\u201355. https:\/\/doi.org\/10.1016\/j.jddst.2018.12.002.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1764_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1208\/s12249-022-02219-7","volume":"23","author":"TF Guimar\u00e3es","year":"2022","unstructured":"Guimar\u00e3es TF, Vital ICF, de Sousa EGR, Boniatti J, Bandini TB, Carr O, et al. Investigation of Chloroquine Resinate feasibility and in Vitro taste masking evaluation for Pediatric formulations. AAPS PharmSciTech. 2022;23:69. https:\/\/doi.org\/10.1208\/s12249-022-02219-7.","journal-title":"AAPS PharmSciTech"},{"issue":"13","key":"1764_CR27","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.3390\/polym13244394","volume":"2021","author":"C Li","year":"2021","unstructured":"Li C, Han X, Hong X, Li X, Zhang H, Wang Z, Zheng A. Study on the complexation and release mechanism of Methylphenidate Hydrochloride Ion Exchange Resin Complex. Polymers. 2021;2021(13):4394. https:\/\/doi.org\/10.3390\/polym13244394.","journal-title":"Polymers"},{"key":"1764_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/polym15051191","volume":"15","author":"JL Yuan","year":"2023","unstructured":"Yuan JL, Li CH, Wang SS, Zhang H, Wang ZM, Zheng AP, et al. Methods and characteristics of drug extraction from Ion-Exchange-Resin-mediated preparations: influences, thermodynamics, and kinetics. Polymers. 2023;15:1191. https:\/\/doi.org\/10.3390\/polym15051191.","journal-title":"Polymers"},{"issue":"11","key":"1764_CR29","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1002\/jps.21706","volume":"98","author":"X Guo","year":"2009","unstructured":"Guo X, Chang R-K, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci. 2009;98(11):3886\u2013902. https:\/\/doi.org\/10.1002\/jps.21706.","journal-title":"J Pharm Sci"},{"key":"1764_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1208\/s12249-023-02592-x","volume":"24","author":"CM Zhu","year":"2023","unstructured":"Zhu CM, Chen JM, Shi LM, Liu Q, Liu CF, Zhang FL, Wu HX. Development of child-friendly lisdexamfetamine chewable tablets using Ion Exchange Resin as a taste-masking carrier based on the Concept of Quality by Design (QbD). AAPS PharmSciTech. 2023;24:132. https:\/\/doi.org\/10.1208\/s12249-023-02592-x.","journal-title":"AAPS PharmSciTech"},{"key":"1764_CR31","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1038\/s41598-018-21214-2","volume":"8","author":"M Sharma","year":"2018","unstructured":"Sharma M, Soni R. Improved therapeutic potential of tapentadol employing cationic exchange resins as carriers in neuropathic pain: evidence from pharmacokinetic and pharmacodynamics study. Sci Rep. 2018;8:2812. https:\/\/doi.org\/10.1038\/s41598-018-21214-2.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"1764_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2018.05.004","volume":"545","author":"R Shang","year":"2018","unstructured":"Shang R, Liu C, Quan P, Zhao HQ, Fang L. Effect of drug-ion exchange resin complex in betahistine hydrochloride orodispersible film on sustained release, taste masking and hygroscopicity reduction. Int J Pharm. 2018;545(1\u20132):163\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.05.004.","journal-title":"Int J Pharm"},{"issue":"4","key":"1764_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1691\/ph.2019.8231","volume":"74","author":"M Saab","year":"2019","unstructured":"Saab M, Mehanna MM. Disintegration time of orally dissolving films: various methodologies and in-vitro\/in-vivo correlation. Pharmazie. 2019;74(4):227\u201330. https:\/\/doi.org\/10.1691\/ph.2019.8231.","journal-title":"Pharmazie"},{"issue":"4","key":"1764_CR34","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1208\/s12249-011-9713-z","volume":"12","author":"AN ElMeshad","year":"2011","unstructured":"ElMeshad AN, El Hagrasy AS, Characterization, Optimization of Orodispersible Mosapride Film Formulations. AAPS PharmSciTech. 2011;12(4):1384\u201392. https:\/\/doi.org\/10.1208\/s12249-011-9713-z.","journal-title":"AAPS PharmSciTech"},{"key":"1764_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejpb.2019.01.011","volume":"136","author":"S Niese","year":"2019","unstructured":"Niese S, Quodbach J. Formulation development of a continuously manufactured orodispersible film containing warfarin sodium for individualized dosing. Eur J Pharm Biopharm. 2019;136:93\u2013101. https:\/\/doi.org\/10.1016\/j.ejpb.2019.01.011.","journal-title":"Eur J Pharm Biopharm"},{"key":"1764_CR36","unstructured":"0941 Content Uniformity Test Method. Chin Pharmacopoeia, 2020. https:\/\/ydz.chp.org.cn\/#\/main. Accessed 2020."},{"key":"1764_CR37","doi-asserted-by":"publisher","first-page":"111137","DOI":"10.1016\/j.msec.2020.111137","volume":"116","author":"X Yin","year":"2020","unstructured":"Yin X, Li L, Gu X, Wang H, Wu L, Qin W, et al. Dynamic structure model of polyelectrolyte complex based controlled-release matrix tablets visualized by synchrotron radiation micro-computed tomography. Mater Sci Eng C. 2020;116:111137. https:\/\/doi.org\/10.1016\/j.msec.2020.111137.","journal-title":"Mater Sci Eng C"},{"issue":"2","key":"1764_CR38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1208\/s12249-017-0881-3","volume":"19","author":"M Kouchak","year":"2018","unstructured":"Kouchak M, Ramezani Z, Bagheri F. Preparation and evaluation of taste Masking Iron suspension: taking advantage of weak Cationic Exchange Resin. AAPS PharmSciTech. 2018;19(2):719\u201329. https:\/\/doi.org\/10.1208\/s12249-017-0881-3.","journal-title":"AAPS PharmSciTech"},{"key":"1764_CR39","unstructured":"Stability testing of new drug substances and products Q1A(R2). ICH Harmonised tripartite guideline, 2003. https:\/\/database.ich.org\/sites\/default\/files\/Q1A%28R2%29%20Guideline.pdf. Accessed Feb 2003."},{"key":"1764_CR40","doi-asserted-by":"publisher","first-page":"102162","DOI":"10.1016\/j.cis.2020.102162","volume":"279","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Wang B, Dutta P. Nanoparticle processing: understanding and controlling aggregation. Adv Colloid Interface Sci. 2020;279:102162. https:\/\/doi.org\/10.1016\/j.cis.2020.102162.","journal-title":"Adv Colloid Interface Sci"},{"issue":"1","key":"1764_CR41","doi-asserted-by":"publisher","first-page":"17386","DOI":"10.1038\/s41598-021-96798-3","volume":"11","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Liu X, Xiong H. Aggregation modeling of the influence of pH on the aggregation of variably charged nanoparticles. Sci Rep. 2021;11(1):17386. https:\/\/doi.org\/10.1038\/s41598-021-96798-3.","journal-title":"Sci Rep"},{"key":"1764_CR42","doi-asserted-by":"publisher","first-page":"101843","DOI":"10.1016\/j.jddst.2020.101843","volume":"59","author":"MS Gupta","year":"2020","unstructured":"Gupta MS, Kumar TP, Gowda DV. Orodispersible Thin Film: a new patient-centered innovation. J Drug Deliv Sci Technol. 2020;59:101843. https:\/\/doi.org\/10.1016\/j.jddst.2020.101843.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"1764_CR43","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s11947-022-02835-y","volume":"15","author":"C Yuan","year":"2022","unstructured":"Yuan C, Sha H, Cui B. Orally disintegrating Film: a New Approach to Nutritional Supplementation. Food Bioproc Tech. 2022;15(12):2629\u201345. https:\/\/doi.org\/10.1007\/s11947-022-02835-y.","journal-title":"Food Bioproc Tech"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01764-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01764-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01764-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:44:32Z","timestamp":1751373872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01764-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1764"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01764-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4823021\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"9 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Palatability assessment was performed in line with the principles of the Declaration of Helsinki. The protocol was approved by the Ethics Committee of Xiangya School of Pharmaceutical Sciences of Central South University [Ethics No. (20220704001)]. The human pharmacokinetic study was strictly conducted following the Declaration of Helsinki and the Code for Quality Management of Pharmaceutical Clinical Trials. The protocol was approved by the Ethics Committee of the Second Affiliated Hospital of Nanhua University [Ethics No. (2022) No. (297)].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have approved the manuscript and agreed to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}